|
|
|
Corporate Profile: Transition Therapeutics
| Summary: |
Transition Therapeutics is focused on the research and development of products primarily for the treatment of central nervous system (CNS) and metabolic disorders.
|
| Address (HQ): |
101 College Street
Suite 220
Toronto, ON M5G 1L7
Canada |
| Phone #'s (HQ): |
| Main |
(416) 260-7770 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
not known |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| TTHI |
| Internet
job postings: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
